Dean L. Shinabarger
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 14
- Clinical Biochemistry top 0.5%
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 9
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 6
-
- RNA and protein synthesis mechanisms 13
- Biochemical and Molecular Research 4
- Cancer therapeutics and mechanisms 4
-
- Bacterial Genetics and Biotechnology 10
-
- Probiotics and Fermented Foods 4
- Co-authors
- M. Clelia GanozaHiroyuki AokiA. M. ChakrabartyAlexander S. MankinSteven SwaneyRandi K. RothmelLiqun XiongThomas B. May
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)Journal of Bacteriology (5 papers)Diagnostic Microbiology and Infectious Disease (5 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Dean L. Shinabarger
47 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 118
- Molecular Medicine 688
- Clinical Biochemistry 600
- Infectious Diseases 1.5k
- Applied Microbiology and Biotechnology 94
- Pharmacology 494
Countries citing papers authored by Dean L. Shinabarger
This map shows the geographic impact of Dean L. Shinabarger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean L. Shinabarger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean L. Shinabarger more than expected).
Fields of papers citing papers by Dean L. Shinabarger
This network shows the impact of papers produced by Dean L. Shinabarger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean L. Shinabarger. The network helps show where Dean L. Shinabarger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dean L. Shinabarger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 22 | |
| 2 | 2018 | 23 | |
| 3 | 2017 | 4 | |
| 4 | 2017 | 46 | |
| 5 | 2017 | 18 | |
| 6 | 2016 | 19 | |
| 7 | 2016 | 24 | |
| 8 | 2015 | 0 | |
| 9 | 2014 | 5 | |
| 10 | 2011 | 15 | |
| 11 | Spontaneous Mutation Frequency and Serial Passage Resistance Development Studies with Ceftaroline (CPT) | 2008 | 6 |
| 12 | 2008 | 153 | |
| 13 | 2007 | 198 | |
| 14 | 2006 | 11 | |
| 15 | 2005 | 10 | |
| 16 | 2000 | 126 | |
| 17 | 1999 | 162 | |
| 18 | 1993 | 79 | |
| 19 | 1993 | 32 | |
| 20 | 1989 | 15 |
About Dean L. Shinabarger
Dean L. Shinabarger is a scholar working on Molecular Medicine, Infectious Diseases, Microbiology, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 48 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), RNA and protein synthesis mechanisms (13 papers), Bacterial Genetics and Biotechnology (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Probiotics and Fermented Foods (4 papers), Biochemical and Molecular Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (688 citations), Clinical Biochemistry (600 citations), Infectious Diseases (1.5k citations), Applied Microbiology and Biotechnology (94 citations) and Pharmacology (494 citations). Dean L. Shinabarger has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include M. Clelia Ganoza, Hiroyuki Aoki, A. M. Chakrabarty, Alexander S. Mankin, Steven Swaney, Randi K. Rothmel, Liqun Xiong, Thomas B. May, Matthew R. Parsek and A. Berry. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Bacteriology, Diagnostic Microbiology and Infectious Disease, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.